A2 Muscle Weakness

Topic

Muscle weakness is defined based on the capacity to generate muscle force and torque: when this capacity falls below the normal pattern of muscle force and torque—the reference value describing how much force and torque a healthy muscle should produce—that reduction constitutes muscle weakness. The further the actual capacity deviates from that normal pattern, the greater the resulting muscle weakness.

This muscle weakness can originate directly within the muscle. Within the muscle, structural damage reduces the tissue capable of contracting and generating force, while atrophy reduces the muscle volume available to produce that same force; both mechanisms diminish the capacity to generate muscle force and torque from within the muscle tissue itself.

In addition to the muscle, muscle weakness can also originate at the neuromuscular junction. Within the neuromuscular junction, myasthenia prevents nerve signals from correctly activating muscle fibers; this failure of activation likewise reduces the capacity to generate muscle force and torque, even though the muscle tissue itself is undamaged.

Along with the muscle and the neuromuscular junction, neural activation is the third possible source of muscle weakness. Regarding neural activation, pain-induced inhibition reduces the signal the nervous system sends to the muscle, while neurological damage disrupts or weakens that same signal before it reaches the muscle; in both cases, the capacity to generate muscle force and torque decreases, even if the muscle and neuromuscular junction are functioning normally.

The model distinguishes between these three sources of muscle weakness—muscle, neuromuscular junction, and neural activation—because each reduces the capacity to generate muscle force and torque via a different pathway and, consequently, requires a different intervention: addressing the muscle does not correct a failure at the neuromuscular junction, and addressing the neuromuscular junction does not correct a failure in neural activation. This distinction regarding origins guides the treatment of muscle weakness: identifying whether the reduction in the capacity to generate muscle force and torque stems from the muscle, the neuromuscular junction, or neural activation allows the intervention to be directed at the mechanism actually limiting that capacity, rather than treating muscle weakness as a single, undifferentiated phenomenon.

ID:502